Abstract
U.K. and U.S. researchers have identified a new ALS susceptibility gene that encodes an RNA-binding protein called FUS. The findings support the idea that the motor neuron disease could arise through a number of protein mishaps, making it unlikely that a single therapy would work for every case. But the relevance of FUS to the majority of ALS cases remains to be elucidated.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.